[The effect on Coxsackie B3 viral infection of these different immunomodifiers: pertussis corpuscular vaccine, purified staphylococcal anatoxin and their combination].
Semenova
I B
IB
Akatov
A K
AK
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D003384:Coxsackievirus Infections / Q000401:mortality / Q000517:prevention & control*; D004353:Drug Evaluation, Preclinical; D029822:Enterovirus B, Human; D051379:Mice; D008807:Mice, Inbred BALB C; D010567:Pertussis Vaccine / Q000627:therapeutic use*; D013208:Staphylococcal Toxoid / Q000627:therapeutic use*; D013997:Time Factors; D017778:Vaccines, Combined / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D010567:Pertussis Vaccine; D013208:Staphylococcal Toxoid; D017778:Vaccines, Combined
Vliianie na Koksaki B3 virusnuiu infektsiiu raznykh immunomodifikatorov: vaktsiny kokliushnoĭ korpuskuliarnoĭ, anatokisna stafilokokkovogo ochishchennogo i ikh kombinatsii.